1. Home
  2. RDY vs SXI Comparison

RDY vs SXI Comparison

Compare RDY & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • SXI
  • Stock Information
  • Founded
  • RDY 1984
  • SXI 1955
  • Country
  • RDY India
  • SXI United States
  • Employees
  • RDY N/A
  • SXI N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • SXI Industrial Machinery/Components
  • Sector
  • RDY Health Care
  • SXI Industrials
  • Exchange
  • RDY Nasdaq
  • SXI Nasdaq
  • Market Cap
  • RDY 2.1B
  • SXI 2.3B
  • IPO Year
  • RDY N/A
  • SXI N/A
  • Fundamental
  • Price
  • RDY $13.24
  • SXI $148.81
  • Analyst Decision
  • RDY Buy
  • SXI Strong Buy
  • Analyst Count
  • RDY 1
  • SXI 3
  • Target Price
  • RDY $17.00
  • SXI $231.33
  • AVG Volume (30 Days)
  • RDY 1.9M
  • SXI 75.4K
  • Earning Date
  • RDY 05-06-2025
  • SXI 05-01-2025
  • Dividend Yield
  • RDY 3.61%
  • SXI 0.85%
  • EPS Growth
  • RDY 2.68
  • SXI N/A
  • EPS
  • RDY 0.75
  • SXI 4.56
  • Revenue
  • RDY $3,637,607,642.00
  • SXI $717,739,000.00
  • Revenue This Year
  • RDY $17.23
  • SXI $10.29
  • Revenue Next Year
  • RDY $9.19
  • SXI $13.91
  • P/E Ratio
  • RDY $17.94
  • SXI $33.14
  • Revenue Growth
  • RDY 14.74
  • SXI N/A
  • 52 Week Low
  • RDY $12.50
  • SXI $148.15
  • 52 Week High
  • RDY $16.89
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • RDY 48.34
  • SXI 24.74
  • Support Level
  • RDY $13.09
  • SXI $157.40
  • Resistance Level
  • RDY $13.85
  • SXI $163.10
  • Average True Range (ATR)
  • RDY 0.14
  • SXI 4.61
  • MACD
  • RDY 0.02
  • SXI -1.29
  • Stochastic Oscillator
  • RDY 19.74
  • SXI 2.21

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

Share on Social Networks: